Joseph R. Testa
机构: Professor, Fox Chase Cancer Center
每年引用次数
引用次数
引用: 51,700
H-指数: 113
I10-指数 : 353
出版物: 553
The proteins encoded by c-akt and v-akt differ in post-translational modification, subcellular localization and oncogenic potential.
Bellacosa A , Tsichlis Pn , Gonzalez-Portal Me , Datta K
Oncogene 8 ( 7) 1957 -1963
150
1993
The ERGB/Fli-1 gene: isolation and characterization of a new member of the family of human ETS transcription factors.
DK Watson , TS Papas , FE Smyth , A Seth
Cell Growth & Differentiation 3 ( 10) 705 -713
87
1992
Recent advances in the molecular analysis of human malignant mesothelioma.
Testa , De Rienzo A
Clinica Terapeutica 151 ( 6) 433 -438
21
2000
Metanephric adenofibroma: robotic partial nephrectomy of a large Wilms' tumor variant.
Al-Saleem T , Uzzo Rg , Canter Dj , Testa
Canadian Journal of Urology 17 ( 4) 5309
7
2010
Molecular implications of recurrent cytogenetic alterations in human small cell lung cancer.
Graziano Sl , Testa
Cancer Detection and Prevention 17 ( 2) 267
14
1993
Acute eosinophilic leukemia with a (10;11) chromosomal translocation.
Schiffer Ca , Fischkoff Sa , Testa
Leukemia 2 ( 6) 394 -397
13
1988
Chromosome translocations in human cancer.
Testa
Cell Growth & Differentiation 1 ( 2) 97 -101
31
1990
Targeting MYC sensitizes malignant mesothelioma cells to PAK blockage-induced cytotoxicity.
Sementino E , Chernoff J , Tan Y , Testa
American Journal of Cancer Research 7 ( 8) 1724 -1737
11
2017
Assessment of methods for the cytogenetic analysis of human solid tumors.
K Tanaka , J R Testa
Journal of the National Cancer Institute 79 ( 6) 1287 -1293
13
1987
Cancer in relatives of leukemic patients with chromosomal rearrangements at rare (heritable) fragile-site locations in their malignant cells.
G H Thomas , J R Testa , B H Cohen , H Abbey
American Journal of Human Genetics 44 ( 6) 811 -819
8
1989
High molecular weight DNA from fixed cytogenetic preparations.
J R Testa , R Snyder , P E Barker , N Z Parsa
American Journal of Human Genetics 39 ( 5) 661 -668
19
1986
Comparative Genomic Hybridization Analysis Detects Frequent, Often High-Level, Overrepresentation of DNA Sequences at 3q, 5p, 7p, and 8q in Human Non-Small Cell Lung Carcinomas
B R Balsara , J R Testa , E Gabrielson , G Sonoda
Cancer Research 57 ( 11) 2116 -2120
149
1997
Prognostic Value of Specific KRAS Mutations in Lung Adenocarcinomas
P Keohavong , J R Testa , J M Siegfried , A T Gillespie
Cancer Epidemiology, Biomarkers & Prevention 6 ( 10) 841 -847
71
1997
Analysis by pulsed field gel electrophoresis reveals complex rearrangements in two MET alleles in a chemically-treated human cell line, MNNG-HOS.
K Arden , M Park , D G Blair , J R Testa
Oncogene 5 ( 10) 1565 -1571
6
1990
Variation amongst K562 cell cultures.
S K Gupta , I W Dimery , J R Testa , A Pollak
Experimental Hematology 11 ( 7) 601 -610
24
1983
Retroviral-like sequences specifically expressed in the rat ovary detect genetic differences between normal and transformed rat ovarian surface epithelial cells.
A K Godwin , P D Miller , L A Getts , K Jackson
Endocrinology 136 ( 10) 4640 -4649
28
1995
The promyelocytic leukemia zinc-finger gene, PLZF, is frequently downregulated in malignant mesothelioma cells and contributes to cell survival.
M Cheung , J Pei , Y Pei , S C Jhanwar
Oncogene 29 ( 11) 1633 -1640
39
2010
EOSINOPHILIC DIFFERENTIATION OF THE HUMAN PROMYELOCYTIC LEUKEMIA CELL LINE, HL-60
S A Fischkoff , A Pollak , G J Gleich , J R Testa
Journal of Experimental Medicine 160 ( 1) 179 -196
124
1984
Re-expression of the tumor suppressor NF2/merlin inhibits invasiveness in mesothelioma cells and negatively regulates FAK.
P I Poulikakos , G-H Xiao , R Gallagher , S Jablonski
Oncogene 25 ( 44) 5960 -5968
136
2006
Transcription Factor DLX5 As a New Target for Promising Antitumor Agents
R A Timakhov , P O Fedichev , A A Vinnik , J R Testa
Acta Naturae 3 ( 3) 47 -51
2
2011